相关实验视频
Updated: Jul 2, 2025

10:37
Induction and Analysis of Epithelial to Mesenchymal Transition
Published on: August 27, 2013
35.8K
RAE1促进胃癌发生和上皮-介质细胞过渡
Wenhui Dong1, Xiaofei Li1, Lulu Cheng1
1Department of Gastroenterology, First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China.
Archives of biochemistry and biophysics
|February 28, 2024
概括
这项研究发现,RAE1表达升高会通过ERK/MAPK通路驱动胃癌 (GC) 细胞入侵和转移. 向RAE1为GC治疗提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 胃癌 (GC) 仍然是一个重大的全球健康挑战,死亡率高.
- 了解驱动GC入侵和转移的分子机制对于开发有效疗法至关重要.
研究的目的:
- 调查RAE1 (Retinoic acid早期转录1) 在胃癌细胞的入侵和转移中的作用.
- 阐明涉及RAE1介导的GC进展的潜在分子途径.
主要方法:
- 使用qRT-PCR和西式涂抹,量化RAE1表达.
- 确立了具有RAE1基因沉默和过度表达的GC细胞系.
- 进行了细胞增殖,迁移和入侵试验.
- 分析了ERK/MAPK通路组件和上皮层-介质细胞过渡 (EMT) 标记物的表达.
主要成果:
- 在GC组织中,RAE1显著上调,与预后不佳相关.
- RAE1敲击抑制了GC细胞的增殖,迁移和入侵.
- 抑制RAE1降低了N-cadherin,维丁,ZEB1,p-ERK1/2和c-Myc,同时增加了E-cadherin.
- 抑制ERK/MAPK通路可以逆转RAE1的转移性作用.
- 在体内,RAE1的敲击抑制了瘤的生长.
结论:
- 通过激活ERK/MAPK信号通路,RAE1促进胃癌细胞的迁移和入侵.
- RAE1代表了胃癌治疗的潜在治疗标.
相关概念视频
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
2.2K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.2K
MAPK Signaling Cascades
5.5K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Small GTPases - Ras and Rho
3.9K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
3.9K

